Silexion Therapeutics (SLXN) Interest Income - Net (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Interest Income - Net of -$32000.0 for Q1 2026, down 455.56% year-over-year from $9000.0 in Q1 2025, and up 53.62% quarter-over-quarter from -$69000.0 in Q4 2025.
Silexion Therapeutics (SLXN) Interest Income - Net (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Interest Income - Net history runs 4 years deep, the most recent figure standing at -$32000.0 for Q1 2026.
- In Q1 2026, Interest Income - Net fell 455.56% year-over-year to -$32000.0; the TTM figure through Mar 2026 stood at -$183000.0 (down 777.78% YoY), while the FY2025 annual figure was -$142000.0, down 14100.0% from the prior year.
- Interest Income - Net for Q1 2026 stood at -$32000.0, up from -$69000.0 in the prior quarter.
- The five-year high for Interest Income - Net was $24000.0 in Q4 2024, with the low at -$69000.0 in Q4 2025.
- The 4-year median for Interest Income - Net is -$33000.0 (2023), against an average of -$26272.7.
- The sharpest annual moves came in 2024 and 2025: Interest Income - Net jumped 172.73% in 2024, then plunged 616.67% in 2025.
- Silexion Therapeutics' Interest Income - Net stood at -$33000.0 in 2023, then surged by 172.73% to $24000.0 in 2024, then plunged by 387.5% to -$69000.0 in 2025, then soared by 53.62% to -$32000.0 in 2026.
- Business Quant data shows SLXN's Interest Income - Net at -$32000.0 in Q1 2026, -$69000.0 in Q4 2025, and -$39000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Income - Net (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | -14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14,000.00 |
| Mar 31, 2026 | -32,000.00 |
| Dec 31, 2025 | -69,000.00 |
| Sep 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -43,000.00 |
| Mar 31, 2025 | 9,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -19,000.00 |
| Dec 31, 2023 | -33,000.00 |
| Sep 30, 2023 | -42,000.00 |
| Jun 30, 2023 | -39,000.00 |